TransCelerate developing privacy position paper

Not-for-profit biopharma consortium TransCelerate BioPharma Inc. (Philadelphia, Pa.) plans to develop a position paper on methods for redacting privacy information found in clinical study reports. The initiative aims to respond to industry trade association positions on clinical trial transparency. Earlier this year, principles were established that voluntarily commit association members to making clinical trial data available to qualified researchers for approved drugs (see BioCentury Extra, Jan. 2).

The consortium also launched an initiative to establish a quality management system for clinical research. ...